Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Primary Care
Neuro-Ophthalmology
Questions discussed in this category
How do you determine when to wean patients with idiopathic intracranial hypertension (IIH) off of acetazolamide?
3 Answers available
What would you recommend for long term management of extensive dural venous sinus thrombosis (CVST) in young females when the only provoking risk factor is combined OCP?
Thrombophilia testing, including JAK2 is negative. When would you stop anticoagulation?
4 Answers available
How do you make the decision to empirically treat for GCA when a patient is referred but cannot be immediately seen in clinic?
When a PCP calls with concern for GCA and is wondering whether to start empiric steroids what data do you prioritize to make that decision and do you ...
4 Answers available
Do you generally recommend low dose aspirin for patients with giant cell arteritis?
2 Answers available
Would you recommend medical therapy for asymptomatic idiopathic intracranial hypertension with completely normal visual field testing?
2 Answers available
How long do you continue steroid-sparing agents such as tocilizumab for GCA once the disease is in remission off steroids?
1 Answer available
16411
20757
18895
12443
12421
8388
Papers discussed in this category
Ann Intern Med, 2020 Sep 22
Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis : A Cohort Study.
Arthritis Rheum,
Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.
Archives of ophthalmology (Chicago, Ill. : 1960), 2010-06
Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale.
BMC musculoskeletal disorders, 2016-08-24
The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.
Stroke, 2023 Sep 07
Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis.
Stroke, 2024 Jan 29
Diagnosis and Management of Cerebral Venous Thrombosis: A Scientific Statement From the American Heart Association.
Related Topics in Primary Care
Lung Cancer
Workload
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Oncology
Palliation
Neuro-Oncology
Gastrointestinal Cancers